


there are currently a number of treatments for Type 2 Diabetes there is always a need for new and better medications. This research study will evaluate how well the study medication controls type 2 diabetes in conjunction with metformin while at the same time evaluating its effectiveness at lowering blood pressure and decreasing weight.
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067. This research study will evaluate how effectively the new investigational oral medication treats Chronic Idiopathic Constipation.
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067.
and 5 million people in this country suffer from the condition. The purpose of this study is to further research the effectiveness of the study medication in treating and preventing gout. The medication in this study has already been FDA approved and in fact is the current standard of care for this condition. This is also an open label study which means that all participants will receive the study medication.
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067. Osteoarthritis of the knee is believed to affect at least 30% of the population over the age of 65. It is a chronically progressive disease with signs and symptoms of pain, stiffness, restricted motion and the sounds or sensation of grating, crackling or popping. As the disease progresses mobility can become severely restricted and eventually lead to joint replacement.
Oral prescription and over-the-counter anti-inflammatory pain relievers are most commonly used as treatments; however, long-term use of these have substantial risk of side effects. At present there is only one topical pain reliever that is FDA approved to treat Osteoarthritis and it has grown in popularity because of its proven effectiveness and safety record. This study is testing the comparative effectiveness of a generic version of this medication. Study Information:
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067.
hypertension. It may be difficult to control, but without adequate treatment high blood pressure can cause health complications. Researchers are actively pursuing new treatments to control hypertension. This important clinical research study is evaluating an investigational combination of FDA-approved oral medicines. Study Information:
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067. This research study will evaluate how effectively the new investigational oral medication treats opioid-induced constipation. Study Information:
Qualified participants will receive:
To qualify for the study you must:
To qualify for the study you must NOT:
To participate in the study or for more information: If you would like to participate in this study please click here and complete the questionnaire. If you would like additional information about participating in this study you can also call 303-399-4067. Be included on our study notification e-mail list. |


